Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 70121-1480

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 70121-1480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Medroxyprogesterone Acetate Injectable Suspension 1)

A forest plot chart showing odds ratios from different studies related to medroxyprogesterone acetate (DMPA) use and associated risk. The x-axis is labeled 'Odds Ratio' with values ranging from 0.6 to 7.4, and data points are shown with confidence intervals for studies by Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012). The plot includes overall subject data and DMPA use for more than or equal to 12 months.*

FDA Label Image

Chemical Structure (Medroxyprogesterone Acetate Injectable Suspension 2)

Chemical structure diagram of medroxyprogesterone acetate showing its steroid backbone with labeled carbon positions and functional groups, including a methyl group and an acetate ester.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 3)

Label for medroxyprogesterone acetate injection, suspension, USP, 150 mg/mL in a 1 mL single-dose vial. Intended for intramuscular use only. The label notes shaking vigorously before use and provides manufacturer information: Amneal Pharmaceuticals LLC, Bridgewater, NJ. Made in Spain.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 4)

Packaging label for medroxyprogesterone acetate 150 mg/mL Injection, Suspension, USP. The label indicates it is for intramuscular use only, supplied as a 1 mL single-dose vial. The labeler is Amneal Pharmaceuticals LLC. The label includes usage instructions to discard unused portions and storage conditions. Manufactured by Laboratorios Farmalan S.A. (Chemo) in Spain.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 5)

Packaging label for medroxyprogesterone acetate injectable suspension USP 150 mg/mL by Amneal Pharmaceuticals LLC. The label indicates it is for intramuscular use only and includes 25 single-dose 1 mL vials. The label also lists storage, usage instructions, manufacturer information (Laboratories Farmalan S.A., Spain), and a barcode.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 6)

Label for medroxyprogesterone acetate 150 mg/mL injectable suspension, USP, for intramuscular use. The product is a 1 mL prefilled single-dose syringe distributed by Amneal Pharmaceuticals LLC. The label includes instructions to shake vigorously before use and notes the product is made in Spain. Lot and expiration date fields are also present but not specified.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 7)

Packaging label for medroxyprogesterone acetate Injectable Suspension, USP 150 mg/mL for intramuscular use. The label indicates a prefilled single-dose syringe. Distributed by Amneal Pharmaceuticals LLC, manufactured by Laboratorios Farmalan S.A. The label includes preparation and needle activation instructions, storage conditions, and formulation ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.